Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune System Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05963217
What this trial is testing

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

Who this might be right for
Relapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma
University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT01103817
What this trial is testing

Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
The Hospital for Sick Children 33
Testing effectiveness (Phase 2)WithdrawnNCT06623240
What this trial is testing

HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Hope Biosciences Research Foundation
Early research (Phase 1)Study completedNCT06013150
What this trial is testing

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Who this might be right for
Anaphylactic Reaction
De Motu Cordis 24
Not applicableLooking for participantsNCT00006150
What this trial is testing

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

Who this might be right for
InfectionsPneumoniaImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT04746950
What this trial is testing

ALICIA (Acalabrutinib in CLL Therapy)

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 90
Testing effectiveness (Phase 2)WithdrawnNCT04353310
What this trial is testing

Evaluating Effects of Curcumin in Moderate to Severe Asthmatics

Who this might be right for
Asthma
Loma Linda University
Not applicableStudy completedNCT02358213
What this trial is testing

Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease

Who this might be right for
Sjogren's Disease
University Hospital, Brest 21
Early research (Phase 1)Looking for participantsNCT07083960
What this trial is testing

OM336 in Autoimmune Cytopenias

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaITP - Immune Thrombocytopenia
Lakefront Biotherapeutics West LLC 32
Early research (Phase 1)Study completedNCT00674024
What this trial is testing

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Testing effectiveness (Phase 2)Ended earlyNCT03913559
What this trial is testing

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Not applicableStudy completedNCT00164762
What this trial is testing

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 126
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Large-scale testing (Phase 3)Study completedNCT02670915
What this trial is testing

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 834
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Early research (Phase 1)Study completedNCT01569750
What this trial is testing

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

Who this might be right for
CD20-positive B-cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 33
Next Page